TRDA
Entrada Therapeutics, Inc. · Healthcare
COO Nathan J Dowden sold $128K of Entrada Therapeutics, Inc.
Sold$127,938
$18.03Price
7,097Shares
−17%Stake
What TRDA did after the filing
- The stock from Thu, Jul 13 open, $15.86
- +2.6%
- S&P 500, same days
- −2.5%
Measured over 30 trading days, to the Aug 24 close.
Traded Mon, Jul 10. Filed Wed, Jul 12, 4:33 PM ET, after the close. Returns use the Jul 13 open and the Aug 24 close. Not investment advice.